Why an MRI costs $1080 in America and $280 in France

I recall reading something about this recently. What if there were a law preventing US drug and medical device companies from charging any less for their products sold abroad than they charge in the US. On other words, they would be precluded from gouging US consumers to the benefit of non-US consumers and would be required to spread the cost of R&D to all customers who benefit from it. Sounds fairer to me, but I concede that the devil is in the details.

We already know the answer to this. The other countries have made it clear that they would no longer honor US patents and would make the items themselves. If that happened, it would be assumed that the other countries would soon be selling their cut-rate products to the US market, either with the tacit approval of the US gummint (the wusses) or, more likely, through some sort of gray or black market (like folks buying their US made products from Canada for less money - because Canada sets the prices lower.) The effect would be the same. Eventually, US companies would stop innovation since their patents are no longer honored. It's a bad deal all around. But the US won't fight this battle. Just as they won't fight the Chinese over patent violations that have been documented. (Yeah, I know. Once in a while they seize a ton or two of knock-offs - but it's not priority.)

So US innovation is subsidizing the world - and it's not just in the pharma industry. But the pharma industry is the last big R&D driven industry in which the US still dominates. That won't last much longer because US citizens (and therefore their government) are getting tired of subsidizing everyone else. We'll kill the goose that laid the golden egg and then wonder why there are no longer golden eggs available. (As Joni Mitchell sang "You don't know what you've got 'til it's gone.") Of course, YMMV.
 
I guess the question then becomes whether it is better to do without innovation or let the scofflaws have a free ride. Hard one. I might prefer to do without.
 
Um, a lot of the Big Pharma companies are in fact foreign companies.

Which still nevertheless use NIH-funded research for a lot of their products.

Didn't someone cite earlier in this thread that they only spend 12% of their revenues on R&D?

They spend more on marketing and advertising, like all the Cialis and Viagra commercials running on TV. Or as noted in another thread, hiring former beauty pageant contestants to call on doctors to prescribe their drugs.

There's more credit being given for "innovation" in the pharmaceuticals industry than there actually is.
 
Um, a lot of the Big Pharma companies are in fact foreign companies.

Yes. In fact, foreign Big Pharma spent slightly more in R&D than US Big Pharma.

Bigpharma R&D spend activity

Which still nevertheless use NIH-funded research for a lot of their products.

How much NIH money is actually given to Big Pharma? I keep hearing/reading that "the US innovates" but there are no numbers.

Sanofi made $28B in revenue from pharma last year and less than $11B of that came from the US. They spent $11B on R&D. How do we tease out the numbers to find the innovation directly from US sales?

Sanofi - Sales by business and region

The top 10 Big Pharma spent about $60B on R&D. The NIH budget is ~$31B/year but not all (little?) of that is Big Pharma (see the Hopkins article below).

There's more credit being given for "innovation" in the pharmaceuticals industry than there actually is.
Agreed.

Federal Government and Big Pharma seen as Increasingly Diminished Source of Research Funding - 11/26/2012

"He says they [pharma & drug device companies] are, understandably, spending research dollars on projects most likely to yield short-term returns, even at the expense of investment in diseases that are severe, common and cannot be prevented or treated effectively."
 
As an addendum, I found this,

Industrial R&D

Even with the ongoing reductions in R&D spending by some of the largest U.S. life science firms, we forecast a slight 1.4% increase in total U.S. life science R&D to $82.7 billion in 2013. This U.S. growth, combined with similar lower levels of growth among European life science firms, but significant growth among Asian life science firms, will lead to 2013 global life science R&D spending of $189.2 billion, a forecast increase of 4.2% from 2012 to 2013.

The US funds 43% of the worldwide R&D funding in life sciences (in corporations). This is by far the most of any other country but the rest of the world does more in aggregate. Are even these foreign R&D costs borne by American consumers, considering that American revenue for Sanofil is 39% (for example)?

What we really need to see is the breakdown of American revenues vs. profits vs. R&D. The OP's article stated that only 12% went to R&D.
 
Here in Lima, you can walk in off the street and get a MRI for S/.400 ($155.00). I know many Canadians who come down to get one and than send the results back home.
 
I think more interesting than the profits of pharmaceuticals would be the profits of hospitals in the US vs. those in other countries.

Of course, what makes it difficult is that a lot of US hospitals are "non-profit" but still generate a lot of money (and pay no taxes?). And in other industrialized countries, hospitals are run by govt. entities.

Also compare compensation of doctors and nurses here and abroad.

In the '60s, it's said that when Canada was considering adopting single-payer, there were a lot of warnings that Canadian doctors would immigrate to the US. In fact, the AMA went up there to spread this campaign. Presumably, there was no mass exodus.
 
Um, a lot of the Big Pharma companies are in fact foreign companies.

Which still nevertheless use NIH-funded research for a lot of their products.

Didn't someone cite earlier in this thread that they only spend 12% of their revenues on R&D?

They spend more on marketing and advertising, like all the Cialis and Viagra commercials running on TV. Or as noted in another thread, hiring former beauty pageant contestants to call on doctors to prescribe their drugs.

There's more credit being given for "innovation" in the pharmaceuticals industry than there actually is.

Regarding OUS Big Pharma companies: True, there are still some Big Pharma companies OUS. But many of them have merged with US Pharma corps. Much of the innovation which accrues to the "foreign" companies is actually done in the US.

The 12% figure that gets bounced around about Big Pharma is in the eye of the beholder. Depends on who is calculating it (and what they use the value for - could even be for political reasons). I'm not an expert on this subject, but I would be very cautious about basing major "political" decisions on that 12% figure. True enough, Big Pharma has it's stake in you believing the number is higher than 12%. So, again, I'm just suggesting we don't buy one number as if it's gospel. I don't have a better number so I'll say no more about the 12%.

It's true that NIH and (so called) tax supported universities do a lot of research for pharma companies. Much of that gets paid for by pharma and there are grants made for specific projects from pharma. So while pharma DOES build on other's research, it's not ALL or even mostly done outside. The BIGGGGGG thing that costs pharma a ton of money is so-called "DEVELOPMENT". It can easily cost $1 Billion dollars to get a drug to market, counting the initial research (in-house or purchased). The biggest costs are to "please" the FDA with ever more studies. It used to be that pharma could use several hundred patients to research safety and efficacy. Now, it typically exceeds 10,000. Protocols for which the gummint and pharma have agreed for the testing can be changed at the (literally) whim of the gummint. Pharma can't have approval without the FDA, so FDA sets the rules (as it goes). Now, please don't misunderstand. We ALL want safe and effective drugs. I personally do not "trust" Big Pharma to be altruistic and produce such drugs without "guidance" (and a big ugly stick). Having said that, having an FDA which is more political than scientific costs US more money when it comes time to purchasing our drugs. The Pharma Companies won't eat those costs. They'll charge us one way or the other. Like I say, they aren't in it to "help" people, they are in it to make money. (I'd like to think most of the PEOPLE in these companies are just like you and I. THEY do indeed do it to help people - as well as to earn a pay check.)

Regarding marketing - I agree that there is way too much of that. Still, I pointed out drug marketing led to a very swift switch from ulcer surgery to ulcer prevention. (I just happen to know about this particular issue). Most other drugs are "over marketed" - but realistically, selling these drugs makes it possible to make new ones. I'd personally rather see some better way of funding such things, but the profit motive has ALWAYS been more successful in bringing new (and usually) better drugs to market than the gummint. Putting the gummint in charge of whether you get a cure for (insert disease here) would seem just about like putting the USPS up against UPS or FEDX. Yes, USPS does deliver the mail, but...

I don't know how to split out the "credit" for who does the innovation. Big as Big Pharma is, they DO DEPEND to some extent upon start-up companies, universities, independent labs, gummint labs, NIH, etc. etc. to get started on a promising compound. It's the Big Pharma that USUALLY sees the potential in what is often BEGUN at these other places. It's also Big Pharma which learns how to make these compounds in sufficient quantity and at low enough price to be viable. So, I'll not argue the point, but say the answer isn't as clear as your statement. For instance, I simply suggest that Big Pharma does indeed do a lot of R&D. Don't think I ever suggested they did it all nor more than anyone else, etc. We NEED all of the various researchers to look for ever more difficult to find drugs to treat ever more difficult to cure illnesses. Big Pharma will gladly take more than their share of the credit, but I didn't give it to them. Still, without Big Pharma, we won't be getting affordable (a relative term) cures/treatments for all kinds of diseases - again, unless you want to turn it over to the folks who brought you the post office and (fill in the blank). I'm not a cheerleader for Big Pharma. I just think they tend to get a bad rap - like BIG (FILL IN THE BLANK). They make a ton of money and a lot of people resent that. I say, if you think Big Pharma (or Big Oil, or Big Food, or Big Three, or Big Anything) seems to have a "lock" on something, you think they can "print" money, you think they have near monopoly, then don't complain about it. BUY THEIR BLOODY STOCK! If you don't then maybe you have doubts about your own view of their "power" and ability to manipulate markets, or take some sort of unfair advantage. If you think Big Pharma is a sure thing, you need to ask how many shares you own.

I've been vocal about this subject because I know at least a little bit about it from tangential involvement in the industry. BUT, if it sounds like I'm a cheerleader, it's the same way I feel about Big Oil finding a huge lake of oil under the Dakotas (or where ever). Yes, they'll make a ton of profit from it, but, in my life time, we are unlikely to run out of oil. I see that as a good thing. Let's not knock Big Pharma either. Both parents had alzheimers. I pray every day that Big Pharma will make an OBSCENE PROFIT from selling ME a drug that will prevent that disease. Of course (and as always) YMMV.
 
Why does an MRI cost $1080 in the US?

Maybe because BMWs and houses in guarded gated communities are expensive.
 
Last edited:
Sadly, there are two huge problems in America which keeps costs sky high. Both of these are not routinely seen in most other countries. The first is the runaway tort actions allowed, and encouraged in our system. The second is the much longer FDA approval time frames for drugs. Of course, it is easier to say the drug and medical device companies are gouging, if you are avoiding tort reform.
it is the elephant in the room.
 
Malpractice accounts for a few billion, a tiny slice of the trillions spent annually in health care spending.

"Defensive medicine" is harder to quantify, partly because in a lot of cases there are economic incentives for providers to order more tests and procedures.

What is more clear are the price differentials, like the same drugs being much cheaper across the border in Canada, or MRIs being much cheaper in other countries, though the machines come from the same cos.

Oh and Congress passed a law prohibiting Americans near the Canadian border from buying their prescription drugs in Canada. Whom do you think that law was passed for?

We know how lobbyists have corrupted the political system, which tries to protect all these industries reap outsized profits.
 
Back
Top Bottom